NYSE:CO - Global Cord Blood Stock Price, News & Analysis

$5.52
+0.08 (+1.47 %)
(As of 08/16/2019 04:00 PM ET)
Today's Range
$5.37
Now: $5.52
$5.63
50-Day Range
$5.42
MA: $5.68
$5.86
52-Week Range
$4.82
Now: $5.52
$7.73
Volume38,700 shs
Average Volume50,171 shs
Market Capitalization$670.96 million
P/E Ratio15.57
Dividend YieldN/A
Beta0.2
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. Read More…

Industry, Sector and Symbol

Industry Holding & other investment offices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone852-3605-8180

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$147.03 million
Cash Flow$0.4266 per share
Book Value$4.20 per share

Profitability

Net Income$43.38 million

Miscellaneous

Employees1,261
Market Cap$670.96 million
Next Earnings Date8/22/2019 (Estimated)
OptionableOptionable

Receive CO News and Ratings via Email

Sign-up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter.


Global Cord Blood (NYSE:CO) Frequently Asked Questions

What is Global Cord Blood's stock symbol?

Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."

How were Global Cord Blood's earnings last quarter?

Global Cord Blood Corp (NYSE:CO) issued its quarterly earnings results on Tuesday, June, 18th. The medical research company reported $0.11 earnings per share (EPS) for the quarter. The medical research company had revenue of $37.50 million for the quarter. Global Cord Blood had a return on equity of 8.84% and a net margin of 29.56%. View Global Cord Blood's Earnings History.

When is Global Cord Blood's next earnings date?

Global Cord Blood is scheduled to release their next quarterly earnings announcement on Thursday, August 22nd 2019. View Earnings Estimates for Global Cord Blood.

Has Global Cord Blood been receiving favorable news coverage?

Press coverage about CO stock has trended negative recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Global Cord Blood earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave media headlines about the medical research company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Global Cord Blood.

Are investors shorting Global Cord Blood?

Global Cord Blood saw a drop in short interest during the month of July. As of July 31st, there was short interest totalling 260,700 shares, a drop of 24.6% from the June 30th total of 345,800 shares. Based on an average trading volume of 62,600 shares, the days-to-cover ratio is currently 4.2 days. Approximately 0.7% of the company's shares are sold short. View Global Cord Blood's Current Options Chain.

Who are some of Global Cord Blood's key competitors?

What other stocks do shareholders of Global Cord Blood own?

Who are Global Cord Blood's key executives?

Global Cord Blood's management team includes the folowing people:
  • Ms. Ting Zheng, Chairman, CEO & Interim CEO of Beijing Division (Age 47)
  • Mr. Albert Chen, CFO & Director (Age 43)
  • Ms. Xin Xu, Chief Technology Officer (Age 65)
  • Ms. Rui Arashiyama, Chief Exec. Officer of Guangdong Division & Zhejiang Division (Age 60)
  • Ms. Cathy Bai, VP of Corp. Fin.

Who are Global Cord Blood's major shareholders?

Global Cord Blood's stock is owned by many different of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (2.33%), Man Group plc (0.74%), Quinn Opportunity Partners LLC (0.21%), SG Americas Securities LLC (0.11%), Parametric Portfolio Associates LLC (0.08%) and Citadel Advisors LLC (0.02%). View Institutional Ownership Trends for Global Cord Blood.

Which major investors are selling Global Cord Blood stock?

CO stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC. View Insider Buying and Selling for Global Cord Blood.

Which major investors are buying Global Cord Blood stock?

CO stock was bought by a variety of institutional investors in the last quarter, including Man Group plc, Renaissance Technologies LLC, SG Americas Securities LLC, Parametric Portfolio Associates LLC and Quinn Opportunity Partners LLC. View Insider Buying and Selling for Global Cord Blood.

How do I buy shares of Global Cord Blood?

Shares of CO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Global Cord Blood's stock price today?

One share of CO stock can currently be purchased for approximately $5.52.

How big of a company is Global Cord Blood?

Global Cord Blood has a market capitalization of $670.96 million and generates $147.03 million in revenue each year. Global Cord Blood employs 1,261 workers across the globe.View Additional Information About Global Cord Blood.

What is Global Cord Blood's official website?

The official website for Global Cord Blood is http://www.globalcordbloodcorp.com/.

How can I contact Global Cord Blood?

Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The medical research company can be reached via phone at 852-3605-8180 or via email at [email protected]


MarketBeat Community Rating for Global Cord Blood (NYSE CO)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  198 (Vote Outperform)
Underperform Votes:  218 (Vote Underperform)
Total Votes:  416
MarketBeat's community ratings are surveys of what our community members think about Global Cord Blood and other stocks. Vote "Outperform" if you believe CO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel